The effect of beta adrenergic antagonists on cardiac contractions, myofibrillar ATPase activity, high-energy phosphate stores and lipid-facilitated transfort of calciumiones.
D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000813:Anilides / Q000494:pharmacology*; D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000378:metabolism*; D002725:Chloroform; D003864:Depression, Chemical; D004285:Dogs; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006352:Heart Ventricles; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D009119:Muscle Contraction / Q000187:drug effects*; D009210:Myofibrils / Q000201:enzymology*; D010210:Papillary Muscles / Q000502:physiology; D010725:Phosphocreatine / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology*; D011817:Rabbits; D013565:Sympatholytics / Q000494:pharmacology*
D000813:Anilides; D013565:Sympatholytics; D010725:Phosphocreatine; D002725:Chloroform; D000255:Adenosine Triphosphate; D011433:Propranolol; D000251:Adenosine Triphosphatases; D002118:Calcium